Loading clinical trials...
Loading clinical trials...
Evaluation of the Tolerance of Anti-MRSA Betalactamines (Ceftaroline / Ceftobiprole) in the Management of BJI / PJI: a Retrospective Study in a Reference Center
Conditions
Interventions
Description of use of ceftaroline and ceftobiprole
Locations
1
France
Hospices Civils de Lyon
Lyon, France
Start Date
February 1, 2020
Primary Completion Date
May 5, 2020
Completion Date
May 5, 2020
Last Updated
June 5, 2020
NCT03850860
NCT05421312
NCT04933344
NCT03850548
NCT03768635
NCT03209934
Lead Sponsor
Hospices Civils de Lyon
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions